Product Information

BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0217 per EA under NDC 64380074108. Its NADAC has been published 586 times since Sep 2, 2015.

FDA first approved this application on Aug 25, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUSPIRONE HCL 5 MG TABLET

Buspirone Hydrochloride
$0.0217per EA

Strength

5 mg/1

NDC

64380074108

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202330

FDA Approved

8/25/2014

TE Code

AB

On Market Since

6/30/2015

Price Statistics

The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 586 times since Sep 2, 2015, and over the history we have for it it has declined 47.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0217 per EA
All-time high$0.0438 (Apr 13, 2016)
All-time low$0.0174 (Nov 20, 2024)
52-week high$0.0221
52-week low$0.0216
Median price$0.0289
Average price$0.0298
Largest weekly change-25.2% (Nov 20, 2024)
Weeks tracked586
Tracking sinceSep 2, 2015

Price History

1W

-0.5%

1M

-1.0%

3M

-0.1%

6M

-1.4%

1Y

-1.4%

3Y

-13.0%

5Y

-13.2%

All

-47.5%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Strides Pharma Inc., is $0.0217 per EA (NDC 64380074108), effective Nov 18, 2026.

How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 47.5%. It has been tracked across 586 weekly CMS publications since Sep 2, 2015.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?

Since Sep 2, 2015, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0438 (Apr 13, 2016), with a median of $0.0289 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUSPIRONE HCL 5 MG TABLET?

BUSPIRONE HCL 5 MG TABLET (NDC 64380074108) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.